22-41150154-C-A
Variant summary
Our verdict is Benign. Variant got -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBS1BS2
The NM_001429.4(EP300):c.2773C>A(p.Pro925Thr) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00606 in 1,611,746 control chromosomes in the GnomAD database, including 41 homozygotes. In-silico tool predicts a benign outcome for this variant. 15/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★★).
Frequency
Consequence
NM_001429.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -20 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
EP300 | NM_001429.4 | c.2773C>A | p.Pro925Thr | missense_variant | 14/31 | ENST00000263253.9 | NP_001420.2 | |
EP300 | NM_001362843.2 | c.2695C>A | p.Pro899Thr | missense_variant | 13/30 | NP_001349772.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
EP300 | ENST00000263253.9 | c.2773C>A | p.Pro925Thr | missense_variant | 14/31 | 1 | NM_001429.4 | ENSP00000263253 | P2 | |
EP300 | ENST00000674155.1 | c.2695C>A | p.Pro899Thr | missense_variant | 13/30 | ENSP00000501078 | A2 | |||
EP300 | ENST00000703544.1 | c.*693C>A | 3_prime_UTR_variant, NMD_transcript_variant | 13/30 | ENSP00000515365 | |||||
EP300 | ENST00000703545.1 | c.*1143C>A | 3_prime_UTR_variant, NMD_transcript_variant | 12/17 | ENSP00000515366 |
Frequencies
GnomAD3 genomes AF: 0.00399 AC: 608AN: 152238Hom.: 6 Cov.: 31
GnomAD3 exomes AF: 0.00388 AC: 952AN: 245168Hom.: 7 AF XY: 0.00384 AC XY: 511AN XY: 133040
GnomAD4 exome AF: 0.00628 AC: 9158AN: 1459390Hom.: 35 Cov.: 32 AF XY: 0.00605 AC XY: 4390AN XY: 726032
GnomAD4 genome AF: 0.00399 AC: 608AN: 152356Hom.: 6 Cov.: 31 AF XY: 0.00387 AC XY: 288AN XY: 74514
ClinVar
Submissions by phenotype
not provided Benign:4
Likely benign, criteria provided, single submitter | not provided | Breakthrough Genomics, Breakthrough Genomics | - | - - |
Benign, criteria provided, single submitter | clinical testing | GeneDx | Nov 14, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Aug 01, 2024 | EP300: BS1, BS2 - |
Benign, criteria provided, single submitter | clinical testing | Center for Pediatric Genomic Medicine, Children's Mercy Hospital and Clinics | Jan 26, 2017 | - - |
not specified Benign:2Other:1
Benign, criteria provided, single submitter | clinical testing | Genetic Services Laboratory, University of Chicago | Sep 26, 2018 | - - |
not provided, no classification provided | reference population | ITMI | Sep 19, 2013 | - - |
Benign, criteria provided, single submitter | clinical testing | Eurofins Ntd Llc (ga) | Apr 22, 2015 | - - |
Rubinstein-Taybi syndrome due to EP300 haploinsufficiency Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 25, 2024 | - - |
Rubinstein-Taybi syndrome due to CREBBP mutations Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Mendelics | May 28, 2019 | - - |
Colorectal cancer;C3150941:Rubinstein-Taybi syndrome due to EP300 haploinsufficiency;C4551859:Rubinstein-Taybi syndrome due to CREBBP mutations;C5193035:Menke-Hennekam syndrome 2 Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | Sep 01, 2021 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at